User contributions for Wilsonsa
From MicrobeWiki, the student-edited microbiology resource
3 November 2010
- 01:1201:12, 3 November 2010 diff hist 0 Telaprevir (VX-950) a novel antiviral treatment for Hepatitis C virus patients →Implications
- 01:1101:11, 3 November 2010 diff hist −69 Telaprevir (VX-950) a novel antiviral treatment for Hepatitis C virus patients →Implications on pharmaceutical industry and individuals infected with Hepatitis C
- 01:0801:08, 3 November 2010 diff hist +3 Telaprevir (VX-950) a novel antiviral treatment for Hepatitis C virus patients →Telaprevir's mechanism of action: protease inhibition
- 01:0601:06, 3 November 2010 diff hist +358 Telaprevir (VX-950) a novel antiviral treatment for Hepatitis C virus patients →Target molecule: NS3-4A serine protease complex
- 01:0601:06, 3 November 2010 diff hist +223 Telaprevir (VX-950) a novel antiviral treatment for Hepatitis C virus patients →Telaprevir's mechanism of action: protease inhibition
- 01:0401:04, 3 November 2010 diff hist −353 Telaprevir (VX-950) a novel antiviral treatment for Hepatitis C virus patients →Target molecule: NS3-4A serine protease complex
- 01:0301:03, 3 November 2010 diff hist +1 Telaprevir (VX-950) a novel antiviral treatment for Hepatitis C virus patients →Telaprevir's mechanism of action: protease inhibitor
- 01:0301:03, 3 November 2010 diff hist +4 Telaprevir (VX-950) a novel antiviral treatment for Hepatitis C virus patients →Genomic structure
- 01:0301:03, 3 November 2010 diff hist +18 Telaprevir (VX-950) a novel antiviral treatment for Hepatitis C virus patients →Pre-clinical profile of telaprevir
- 01:0201:02, 3 November 2010 diff hist −21 Telaprevir (VX-950) a novel antiviral treatment for Hepatitis C virus patients →Mechanism of telaprevir action: inhibition of viral protease, NS3-4A
- 01:0101:01, 3 November 2010 diff hist +1,041 Telaprevir (VX-950) a novel antiviral treatment for Hepatitis C virus patients →Pre-clinical profile of telaprevir
- 00:4900:49, 3 November 2010 diff hist +10 Telaprevir (VX-950) a novel antiviral treatment for Hepatitis C virus patients →Challenges of HCV anti-viral drug discovery and development
- 00:4800:48, 3 November 2010 diff hist −229 Telaprevir (VX-950) a novel antiviral treatment for Hepatitis C virus patients →Discovery and optimization of telaprevir
- 00:4800:48, 3 November 2010 diff hist +65 Telaprevir (VX-950) a novel antiviral treatment for Hepatitis C virus patients →HCV replication cyle
- 00:4700:47, 3 November 2010 diff hist −108 Telaprevir (VX-950) a novel antiviral treatment for Hepatitis C virus patients →Telaprevir (VX-950), a novel antiviral treatment for Hepatitis C
- 00:4600:46, 3 November 2010 diff hist +1,571 Telaprevir (VX-950) a novel antiviral treatment for Hepatitis C virus patients →Telaprevir (VX-950), a novel antiviral treatment for Hepatitis C
- 00:4600:46, 3 November 2010 diff hist −1,404 Telaprevir (VX-950) a novel antiviral treatment for Hepatitis C virus patients →Challenges of HCV anti-viral drug discovery and development
- 00:4200:42, 3 November 2010 diff hist +180 Telaprevir (VX-950) a novel antiviral treatment for Hepatitis C virus patients →Discovery and optimization of telaprevir
2 November 2010
- 23:4423:44, 2 November 2010 diff hist −2 Telaprevir (VX-950) a novel antiviral treatment for Hepatitis C virus patients →HCV replication cyle
- 23:4323:43, 2 November 2010 diff hist −55 Telaprevir (VX-950) a novel antiviral treatment for Hepatitis C virus patients →Hepatitis C virus genome and replication cycle